Serum protein pattern in sarcoidosis analysed by a proteomics approach

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 21, Issue 3, 2004, Pages 182-190

  Sabounchi Schütt, Fariba ^a   Mikko, Mikael ^a   Eklund, Anders ^a   Grunewald, Johan ^a   Åström, Jonas ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b GE Healthcare Bio Sciences AB   (Sweden)

Author keywords

2 D PAGE protein profiling; Protein spot pattern; Sarcoidosis; Serum

Indexed keywords

PLASMA PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LUNG LAVAGE; MALE; OPTICAL DENSITY; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SARCOIDOSIS;

ADULT; BLOOD PROTEINS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; PROTEOMICS; SARCOIDOSIS;

EID: 8144223843     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hunninghake GW, Costabel U, Ando M, et al: ATS/ERS/WASOG Statement on sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-173.
2. Hunninghake GW, Fulmer JD, Young RC Jr, Gadek JE, Crystal RG: Localization of the immune response in sarcoidosis. Am Rev Respir Dis 1979; 120: 49-57.
3. Semenzato G, Bortoli M, Agostini C: Applied clinical immunology in sarcoidosis. Curr Opin Pulm Med 2002; 8: 441-4.
4. Sabounchi-Schutt F, Astrom J, Hellman U, Eklund A, Grunewald J: Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: Aproteomics approach. Eur Respir J 2003; 21: 414-20.
5. Bini L, Magi B, Cellesi C, Rossolini A, Pallini V: Two-dimensional electrophoresis analysis of human serum proteins during the acute-phase response. Electrophoresis 1992; 13: 743-6.
6. Lindahl M, Ekstrom T, Sorensen J, Tagesson C: Two dimensional protein patterns of bronchoalveolar lavage fluid from non-smokers, smokers, and subjects exposed to asbestos. Thorax 1996; 51: 1028-35.
7. Wattiez R, Hermans C, Cruyt C, Bernard A, Falmagne P: Human bronchoalveolar lavage fluid protein two-dimensional database: Study of interstitial lung diseases. Electrophoresis 2000; 21: 2703-12.
8. Hermans C, Bernard A: Lung epithelium-specific proteins: Characteristics and potential applications as markers. Am J Respir Crit Care Med 1999; 159: 646-78.
9. Eklund A, Blaschke E: Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarcoidosis. Thorax 1986; 41: 629-34.
10. Sabounchi-Schutt F, Astrom J, Olsson I, Eklund A, Grunewald J, Bjellqvist B: An immobiline drystrip application method enabling high-capacity two-dimensional gel electrophoresis. Electrophoresis 2000; 21: 3649-56.
11. Löfgren S, Lundbäck H: The bilateral hilar lymphoma syndrome. Acta Med Scand; CXLLI, fasc IV: 1952: 265-73.
12. Winterbauer RH, Lammert J, Selland M, Wu R, Corley D, Springmeyer SC: Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 1993; 104: 352-36113.
13. Magi B, Bini L, Perari MG, et al: Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: A two-dimensional electrophoretic study. Electrophoresis 2002; 23: 3434-44.
14. Liberatori S, Bini L, De Felice C, et al: A two-dimensional protein map of human amniotic fluid at 17 weeks' gestation. Electrophoresis 1997; 18: 2816-22.
15. Check IJ, Kidd MR, Staton GW Jr: Systemic and lung protein changes in sarcoidosis. Lymphocyte counts, gallium uptake values, and serum angiotensin-converting enzyme levels may reflect different aspects of disease activity. Ann N Y Acad Sci 1986; 465: 407-17.
16. Liberatori S, Bini L, De Felice C, et al: Acute-phase proteins in perinatal human plasma. Electrophoresis 1997; 18: 520-6.
17. Salazar A, Mana J, Pinto X, et al: Low levels of high density lipoprotein cholesterol in patients with active sarcoidosis. Atherosclerosis 1998; 136: 133-7.
18. Muller-Quernheim J, Kronke M, Strausz J, Schykowski M, Ferlinz R: Interleukin-2 receptor gene expression by bronchoalveolar lavage lymphocytes in pulmonary sarcoidosis. Am Rev Respir Dis 1989; 140: 82-8.
19. Salazar A, Mana J, Fiol C, et al: Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis. Atherosclerosis 2000; 152: 497-502.
20. Parrish RW, Williams JD, Davies BH: Serum beta-2-microglobulin and angiotensin-converting enzyme activity in sarcoidosis. Thorax 1982; 37: 936-40.
21. Selroos OB. Biochemical markers in sarcoidosis. Crit Rev Clin Lab Sci 1986; 24: 185-216.
22. Silverstein E, Pertschuk LP, Friedland J: Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas. Proc Natl Acad Sci USA 1979; 76: 6646-8.
23. Nguyen MD, Simpson-Haidaris PJ: Cell type-specific regulation of fibrinogen expression in lung epithelial cells by dexamethasone and interleukin-1beta. Am J Respir Cell Mol Biol 2000; 22: 209-17.
24. Sabounchi-Schutt F, Astrom J, Eklund A, Grunewald J, Bjellqvist B: Detection and identification of human bronchoalveolar lavage proteins using narrow-range immobilized pH gradient drystrip and the paper bridge sample application method. Electrophoresis 2001; 22: 1851-60.
25. Gebe JA, Kiener PA, Ring HZ, Li X, Francke U, Aruffo A: Molecular cloning, mapping to human chromosome 1 q21-q23, and cell binding characteristics of Spα, a new member of the scavenger receptor cysteine-rich (SRCR) family of proteins. J Biol Chem 1997; 272: 6151-8.
26. von Bredow C, Birrer P, Griese M: Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis. Eur Respir J 2001; 17: 716-22.
27. Milman N, Thymann M, Graudal N, Morling N: Plasma vitamin D-binding protein (gc) factors, immunoglobulin G heavy chain (gm) allotypes and immunoglobulin kappa light chain (km1) allotype in patients with sarcoidosis and in healthy control subjects. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 97-100.
28. Manfredi AA, Rovere P, Heltai S, et al: Apoptotic cell clearance in systemic lupus erythematosus. li. Role of beta2-glycoprotein I. Arthritis Rheum 1998; 41: 215-23.
29. Dong X, Wang J, Kabir FN, et al: Autoantibodies to DEK oncoprotein in human inflammatory disease. Arthritis Rheum 2000; 43: 85-93.
30. Yamada K, Senju S, Nakatsura T, et al: Identification of a novel autoantigen UACA in patients with panuveitis. Biochem Biophys Res Commun 2001; 280: 1169-76.